Category Archives: Transhuman News

Detox, DNA Activation, Mind Body Transformation
Welcome to the LumenOctave: A state-of-the-art, body-centered consciousness program that returns your body to its healthy, vibrant state and proper functioning! Join us at http://www.lumenoctave....

By: Indra Mona

More here:
Detox, DNA Activation, Mind Body Transformation - Video

For more than two decades, Anthony Wright has insisted that he did not rape and kill 77-year-old Louise Talley in Nicetown.

He was working construction at the time of her death, he has said, adding that his confession came only after coercion from police, who he says threatened him while he was handcuffed to a chair.

And the bloodstained clothes that police removed from his house? Not his either, he has maintained.

He has made these claims from behind bars, where he is serving a life sentence for the 1991 slaying.

DNA testing sophisticated enough to exonerate him was not available in 1993, when a jury found him guilty, but it is now. And so for nine years his attorneys have pushed to see if advances in technology would support his case.

The results of those tests are back. They show it was someone else's DNA found in bodily fluids taken from the victim, say his attorneys, with the Innocence Project at Yeshiva University's Benjamin N. Cardozo Law School.

That DNA, the attorneys say in court pleadings, belonged to a career criminal and crack addict named Ronnie Byrd, who died early last year in South Carolina.

The bloodstained clothes, they say, turn out not to bear Wright's DNA either. The garments belonged to the woman who was killed.

Continued here:
DNA tests from 1991 rape-murder point to a new suspect

WEDNESDAY, Sept. 17, 2014 (HealthDay News) -- A blood test that measures DNA from a prostate cancer tumor could provide doctors with a better assessment of the state of a man's disease, a new study suggests.

If used routinely, this blood test could reveal when treatment for advanced prostate cancer stops working and actually begins promoting tumor growth, the researchers suggested.

"Our study showed that a steroid treatment given to patients with advanced prostate cancer and often initially very effective started to activate harmful mutations and coincided with the cancer starting to grow again," study leader Dr. Gerhardt Attard, from the Institute of Cancer Research (ICR) in London, explained in an ICR news release.

"In the future, we hope to routinely monitor genetic mutations in patients with advanced disease using just a blood test -- enabling us to stop treatments when they become disease drivers and select the next best treatment option. We need to confirm these findings in larger numbers of patients, but using these types of blood tests could allow true personalization of treatment for prostate cancer patients, based on the cancer mutations we detect," he explained.

Using a blood test to measure circulating tumor DNA levels is less expensive and less invasive than needle biopsies. This test could be an effective way to monitor the emergence of treatment-resistant prostate cancer, the study published on Sept. 17 in Science Translational Medicine suggested.

"Drug resistance is the single biggest challenge we face in cancer research and treatment, and we are just beginning to understand how its development is driven by evolutionary pressures on tumors," Paul Workman, interim chief executive at the ICR, said in the news release.

This discovery "reveals how some cancer treatments can actually favor the survival of the nastiest cancer cells, and sets out the rationale for repeated monitoring of patients using blood tests, in order to track and intervene in the evolution of their cancers," Workman said.

"There are currently too few treatment options for men living with advanced stage prostate cancer. Not only do we desperately need to find more treatments for this group of men, we also need to understand more about when those that are available stop working and why," Dr. Matthew Hobbs, deputy director of research at Prostate Cancer UK, said in the news release.

"This research is important as it shows that there might be a new way to monitor how a man's cancer is changing during treatment, and that could help us to pinpoint the stage at which some drugs stop being effective. In the future, this could arm doctors with the knowledge they need to ensure that no time is wasted between a drug that stops working for a man and him moving on to another effective treatment," Hobbs said.

But, Hobbs also noted that this is preliminary research and that the study size was small -- just 16 men. He agreed with Attard that the findings need to be confirmed in a larger study.

View original post here:
DNA Blood Test Might Identify Status of Prostate Cancer